Generalized Likelihood Ratios for Designing Dose Optimization Studies of Targeted Therapies
出版年份 2023 全文链接
标题
Generalized Likelihood Ratios for Designing Dose Optimization Studies of Targeted Therapies
作者
关键词
-
出版物
Statistics in Biopharmaceutical Research
Volume -, Issue -, Pages 1-17
出版商
Informa UK Limited
发表日期
2023-10-05
DOI
10.1080/19466315.2023.2267494
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bayesian adaptive model selection design for optimal biological dose finding in phase I/II clinical trials
- (2021) Ruitao Lin et al. BIOSTATISTICS
- The Drug-Dosing Conundrum in Oncology — When Less Is More
- (2021) Mirat Shah et al. NEW ENGLAND JOURNAL OF MEDICINE
- The i3+3 design for phase I clinical trials
- (2019) Meizi Liu et al. Journal of Biopharmaceutical Statistics
- BOIN-ET: Bayesian optimal interval design for dose finding based on both efficacy and toxicity outcomes
- (2018) Kentaro Takeda et al. PHARMACEUTICAL STATISTICS
- STEIN: A simple toxicity and efficacy interval design for seamless phase I/II clinical trials
- (2017) Ruitao Lin et al. STATISTICS IN MEDICINE
- Toxicity and Efficacy Probability Interval Design for Phase I Adoptive Cell Therapy Dose-Finding Clinical Trials
- (2016) Daniel H. Li et al. CLINICAL CANCER RESEARCH
- An adaptive dose-finding method using a change-point model for molecularly targeted agents in phase I trials
- (2016) Hiroyuki Sato et al. STATISTICS IN MEDICINE
- Adaptive designs for identifying optimal biological dose for molecularly targeted agents
- (2014) Yong Zang et al. Clinical Trials
- Seamless Phase I/II Adaptive Design for Oncology Trials of Molecularly Targeted Agents
- (2014) Nolan A. Wages et al. Journal of Biopharmaceutical Statistics
- Bayesian optimal interval designs for phase I clinical trials
- (2014) Suyu Liu et al. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS
- Early phase clinical trials to identify optimal dosing and safety
- (2014) Natalie Cook et al. Molecular Oncology
- An adaptive dose-finding approach for correlated bivariate binary and continuous outcomes in phase I oncology trials
- (2011) Akihiro Hirakawa STATISTICS IN MEDICINE
- A modified toxicity probability interval method for dose-finding trials
- (2010) Yuan Ji et al. Clinical Trials
- Toxicity equivalence range design (TEQR): A practical Phase I design
- (2010) M. Suzette Blanchard et al. Contemporary Clinical Trials
- Two-stage design for dose-finding that accounts for both efficacy and safety
- (2008) Vladimir Dragalin et al. STATISTICS IN MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now